154 Results

People

  1. Gonen
    Gonen
  2. Motzer
    Motzer
  3. Saltz
    Saltz
  4. Dee
    Dee
  5. D'Angelica
    D'Angelica
  6. DeMatteo
    DeMatteo
  7. Jarnagin
    Jarnagin
  8. Kingham
    Kingham
  9. Abrey
    Abrey
  10. Hultcrantz
    Hultcrantz

Groups

  1. Department of Medicine (67)
  2. Solid Tumor Oncology Division (43)
  3. Surgery (37)
  4. Epidemiology and Biostatistics (27)
  5. Center for Hematologic Malignancies (24)
  6. Hematologic Malignancies, Division of (23)
  7. Survivorship Research (23)
  8. Biostatistics Service (19)
  9. Population Sciences Research Program (19)
  10. Sloan Kettering Institute Postdocs (18)
  1. "hazard ratio"
Formats
  1. Journal Article (149)
  2. Editorial (2)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (67)
  2. Solid Tumor Oncology Division (43)
  3. Surgery (37)
  4. Epidemiology and Biostatistics (27)
  5. Center for Hematologic Malignancies (24)
  6. Hematologic Malignancies, Division of (23)

More Groups

People
  1. Mithat Gonen (9)
  2. Leonard Saltz (6)
  3. Robert Motzer (6)
  4. Edward Christopher Dee (5)
  5. Michael D'Angelica (4)
  6. Ronald DeMatteo (4)

More People

Years
  1. 2025 (6)
  2. 2024 (25)
  3. 2023 (17)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Annals of Surgical Oncology (9)
  3. International Journal of Radiation Oncology, Biology, Physics (7)
  4. Cancer (6)
  5. Gynecologic Oncology (6)
  6. Lancet Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (21)
  2. Elsevier Science, Inc. (18)
  3. American Society of Clinical Oncology (16)
  4. Springer (12)
  5. Wiley Blackwell (12)
  6. Oxford University Press (11)

More Publishers

Results (154)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Statin use and mortality risk in Asian patients with prostate cancer receiving androgen deprivation therapy: A population-based cohort study
    Journal Article

    Lee, Y. H. A.; Chan, J. S. K.; Hui, J. M. H.; Tang, P.; Liu, K.; Dee, E. C.; Ng, K.; Tse, G.; Ng, C. F.
    Cancer Medicine (2024)

    Fulltext@MSK | Save
  • Diabetes care in the oncologic population
    Journal Article

    Presswala, L. S.; Farooki, A.; Flory, J.
    Contemporary Endocrinology (2023)

    Fulltext@MSK | Save
  • Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
    Journal Article

    Hahn, A. W.; Kotecha, R. R.; Viscuse, P. V.; Pieretti, A. C.; Wiele, A. J.; Jonasch, E.; Lee, C. H.; Gao, J.; Zurita, A. J.; Shah, A. Y.; more...
    European Urology Focus (2023)

    Fulltext@MSK | Save
  • EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
    Journal Article

    Rosenberg, J. E.; Powles, T.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Immunotherapy and transarterial radioembolization combination treatment for advanced hepatocellular carcinoma
    Journal Article

    Yeo, Y. H.; Liang, J.; Lauzon, M.; Luu, M.; Noureddin, M.; Ayoub, W.; Kuo, A.; Sankar, K.; Gong, J.; Hendifar, A.; more...
    American Journal of Gastroenterology (2023)

    Fulltext@MSK | Save
  • Lymph node metastases and associated recurrence-free survival in microsatellite stable and unstable colon cancer
    Journal Article

    Hakki, L.; Khan, A.; Gonen, M.; Stadler, Z.; Segal, N. H.; Shia, J.; Widmar, M.; Wei, I. H.; Smith, J. J.; Pappou, E. P.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: Diagnostic performance and outcomes using biparametric vs. multiparametric MRI
    Journal Article

    Woo, S.; Becker, A. S.; Das, J. P.; Ghafoor, S.; Arita, Y.; Benfante, N.; Gangai, N.; Teo, M. Y.; Goh, A. C.; Vargas, H. A.
    Cancer Imaging (2023)

    Fulltext@MSK | Save
  • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial
    Journal Article

    Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Lee, W. J.; Goetze, T. O.; more...
    Lancet (2023)

    Fulltext@MSK | Save
  • A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
    Journal Article

    Han, S. N.; Oza, A.; Colombo, N.; Oaknin, A.; Raspagliesi, F.; Wenham, R. M.; Braicu, E. I.; Jewell, A.; Makker, V.; Krell, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save